# Suzhou Keyin Biomedical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/suzhou-keyin-biomedical-technology

- Industry: Biotechnology
- Headquarters: Suzhou, China
- Latest round: Series A (Aug 26, 2021)
- Investors on record: 2

## About

Based in Suzhou, China and founded in 2020, Suzhou Keyin Biomedical Technology is a medical company dedicated to the research and development of new drugs enabled by AI technology. In August 2021, Suzhou Keyin Biomedical Technology raised more than RMB 10 million in series A funding led by Sherpa Venture Capital and followed by Frees Fund. The founding team of the company has years of experience in chemical biology, biophysics, computational chemistry and artificial intelligence. 

At present, the company has built the De novo drug design platform, which can explore the whole chemical space and enhance the virtual discovery ability for new targets. The team focuses on early targets in the field of tumor and immunity, and provide patients with the small molecule drugs.

## Funding rounds

- Series A, Aug 26, 2021 — Frees Fund, Sherpa Healthcare Partners

## Investors

- Frees Fund (https://capitalatlas.ai/funds/frees-fund) — Series A
- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Series A